世界の体外診断用医薬品市場2021-2027:製品別、用途別、技術別(免疫化学、分子診断)、最終用途別、地域別

◆英語タイトル:In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics), By End-use, By Region, And Segment Forecasts, 2021 - 2027
◆商品コード:GV21MC083
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年1月19日
◆ページ数:200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の体外診断用医薬品市場規模が2027年までに1,139憶ドルに達すると予測しています。2021年から2027年までに年平均4.5%成長する見通しです。本調査レポートでは、体外診断用医薬品の世界市場について調査・分析し、調査範囲・手法、市場定義、エグゼクティブサマリー、市場変動・動向・範囲、製品別(器具、試薬、サービス)分析、技術別(イムノアッセイ、血液学、臨床化学、分子診断、凝固)分析、用途別(感染症、糖尿病、腫瘍、心臓病、腎臓病)分析、最終用途別(病院、研究所、在宅医療、その他)分析、地域別分析、競争分析などを掲載しています。
・調査範囲・手法
・市場定義
・エグゼクティブサマリー
・市場変動・動向・範囲
・体外診断用医薬品の世界市場規模:製品別(器具、試薬、サービス)
・体外診断用医薬品の世界市場規模:技術別(イムノアッセイ、血液学、臨床化学、分子診断、凝固)
・体外診断用医薬品の世界市場規模:用途別(感染症、糖尿病、腫瘍、心臓病、腎臓病)
・体外診断用医薬品の世界市場規模:最終用途別(病院、研究所、在宅医療、その他)
・体外診断用医薬品の世界市場規模:地域別
・競争分析
【レポートの概要】

In Vitro Diagnostics Market Growth & Trends

The global in vitro diagnostics market size is expected to reach USD 113.9 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.5% from 2021 to 2027. The growth is driven by the growing geriatric population and technological advancements in diagnostics that are supporting its adoption.

Technological advancements in terms of accuracy, portability, and cost-effectiveness are expected to be one of the high impact rendering drivers of this market. For instance, in June 2017, Agena Bioscience launched the MassARRAY system integrated with CHIP Prep Module in Europe. The system was marketed as a CE-IVD product under Directive 98/79/EC. Moreover, Real-Time Polymerase Chain Reaction (qPCR) is one of the fastest-growing application segments of the in vitro diagnostics (IVD) market.

The IVD market is highly competitive in nature. Consequently, manufacturers are required to improvise products in terms of specificity, accuracy, precision, speed, and other parameters, in order to gain an advantage over previously marketed products.

A steady rise in consumer awareness about diagnosing infectious diseases and increasing disease prevalence, especially in developing and under-developed countries, are driving the market penetration of the products. For instance, in February 2019, Abbott received CE Mark for DETERMINE HBSAG 2 test for detection and diagnosis of hepatitis B surface antigen.

Organizations promote funding to support R&D and product development exercises pertaining to clinical diagnostics. For instance, Vela Diagnostics received USD 225,000 as Biomedical Advanced Research and Development Authority (BARDA) fund to develop COVID-19 tests. Moreover, the introduction of the American Health Care Act of 2017 is expected to improve the healthcare of the U.S. Rising government initiatives pertaining to the importance of IVD will fuel market growth.

The presence of effective technologies such as molecular diagnostics is expected to reduce the threat of substitutes. Moreover, their contribution in the field of genetic testing is of paramount importance and, therefore, experience a low threat of substitutes. However, high prices of these tests are expected to encourage patients to shift to external substitutes.

Major players in the market are Roche Diagnostics; Becton Dickinson; Abbott Laboratories; Siemens; and bioMerieux, which are well-established. Therefore, local companies and new organizations have little scope to enter the market and ensure sustainability. However, companies such as Danaher Corporation and Hologic have successfully excelled in the market through mergers and acquisitions. The seed capital required is high.

In Vitro Diagnostics Market Report Highlights

• Molecular diagnostics is expected to witness the fastest growth over the forecast period

• High use of reagents in IVD testing, high demand for over-the-counter diagnostic tests, and increase in adoption of these tests in nonmedical facilities, such as home, are some of the factors that are driving the growth, providing it a clinical advantage over other IVD tests

• Reagents held the largest market share in 2020 owing to the increasing demand for genetic testing and availability of technologically advanced cancer diagnostic tests in countries with unmet clinical needs, such as India and Middle East & Africa

• The growing availability of CE-IVD certified kits globally to diagnose and screen patients during epidemic situations is expected to boost the growth of reagents and instruments segments

• Key players are updating their range of testing options for qPCR instruments by undertaking R&D initiatives for the development of kits that target emerging diseases, or by entering into agreements with other kit manufacturing companies

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Global IVD Market Variables, Trends & Scope
4.1 IVD Market Lineage Outlook
4.1.1 Parent Market outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Regulatory Framework
4.3.1 Market Driver Analysis
4.3.2 Growing geriatric population
4.3.3 Technological advancements
4.3.4 Increasing demand for POC facilities
4.3.5 Growing prevalence of target diseases, such as genetic, cardiovascular, and neurological diseases, and hospital-acquired infections
4.3.6 Outbreak of COVID-19
4.4 Market Restraint Analysis
4.4.1 Higher cost of devices
4.4.2 Stringent regulatory policies
4.5 SWOT Analysis, by factor (Political & Legal, Economic, and Technological)
4.6 Porter’s Five Forces Analysis
4.7 Major deals and strategic alliances analysis
4.7.1 New product launch
4.7.2 Mergers and acquisitions
4.7.3 Expansion
4.7.4 Partnerships
4.7.5 Marketing & promotions
4.7.6 Market entry strategies
4.7.7 Mergers and Deals
Chapter 5 IVD Market – Segment Analysis, by Product, 2016 – 2027 (USD Million)
5.1 In Vitro Diagnostic Market: Products Movement Analysis
5.2 Instruments
5.2.1 Instruments market estimates and forecast, 2016 – 2027 (USD Million)
5.3 Reagents
5.3.1 Reagents market estimates and forecast, 2016 – 2027 (USD Million)
5.4 Services
5.4.1 Services market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 6 IVD Market – Segment Analysis, by Technology, 2016 – 2027 (USD Million)
6.1 In Vitro Diagnostics Market: Technology Movement Analysis
6.2 Immunoassay
6.2.1 Immunoassay market estimates and forecast, 2016 – 2027 (USD Million)
6.2.2 Instruments
6.2.2.1 Instruments market for immunoassay estimates and forecast, 2016 – 2027 (USD Million)
6.2.3 Reagents
6.2.3.1 Reagents market for immunoassay estimates and forecast, 2016 – 2027 (USD Million)
6.2.4 Services
6.2.4.1 Services market for immunoassay estimates and forecast, 2016 – 2027 (USD Million)
6.3 Hematology
6.3.1 Hematology market estimates and forecast, 2016 – 2027 (USD Million)
6.3.2 Instruments
6.3.2.1 Instruments market for hematology estimates and forecast, 2016 – 2027 (USD Million)
6.3.3 Reagents
6.3.3.1 Reagents market for hematology estimates and forecast, 2016 – 2027 (USD Million)
6.3.4 Services
6.3.4.1 Services market for hematology estimates and forecast, 2016 – 2027 (USD Million)
6.4 Clinical Chemistry
6.4.1 Clinical Chemistry market estimates and forecast, 2016 – 2027 (USD Million)
6.4.2 Instruments
6.4.2.1 Instruments market for clinical chemistry estimates and forecast, 2016 – 2027 (USD Million)
6.4.3 Reagents
6.4.3.1 Reagents market for clinical chemistry estimates and forecast, 2016 – 2027 (USD Million)
6.4.4 Services
6.4.4.1 Services market for clinical chemistry estimates and forecast, 2016 – 2027 (USD Million)
6.5 Molecular Diagnostics
6.5.1 Moecular diagnostics market estimates and forecast, 2016 – 2027 (USD Million)
6.5.2 Instruments
6.5.2.1 Instruments market for molecular diagnostics estimates and forecast, 2016 – 2027 (USD Million)
6.5.3 Reagents
6.5.3.1 Reagents market for molecular diagnostics estimates and forecast, 2016 – 2027 (USD Million)
6.5.4 Services
6.5.4.1 Services market for molecular diagnostics estimates and forecast, 2016 – 2027 (USD Million)
6.6 Coagulation
6.6.1 Coagulation market estimates and forecast, 2016 – 2027 (USD Million)
6.6.2 Instruments
6.6.2.1 Instruments market for coagulation estimates and forecast, 2016 – 2027 (USD Million)
6.6.3 Reagents
6.6.3.1 Reagents market for coagulation estimates and forecast, 2016 – 2027 (USD Million)
6.6.4 Services
6.6.4.1 Services market for coagulation estimates and forecast, 2016 – 2027 (USD Million)
6.7 Microbiology
6.7.1 Microbiology market estimates and forecast, 2016 – 2027 (USD Million)
6.7.2 Instruments
6.7.2.1 Instruments market for microbiology estimates and forecast, 2016 – 2027 (USD Million)
6.7.3 Reagents
6.7.3.1 Reagents market for microbiology estimates and forecast, 2016 – 2027 (USD Million)
6.7.4 Services
6.7.4.1 Services market for microbiology estimates and forecast, 2016 – 2027 (USD Million)
6.8 Others
6.8.1 Others market estimates and forecast, 2016 – 2027 (USD Million)
6.8.2 Instruments
6.8.2.1 Instruments Others market estimates and forecast, 2016 – 2027 (USD Million)
6.8.3 Reagents
6.8.3.1 Reagents market estimates and forecast, 2016 – 2027 (USD Million)
6.8.4 Services
6.8.4.1 Services market for other technology estimates and forecast, 2016 – 2027 (USD Million)
Chapter 7 IVD Market – Segment Analysis, by Application, 2016 – 2027 (USD Million)
7.1 In Vitro Diagnostic Market: Application Movement Analysis
7.2 Infectious Diseases
7.2.1 Infectious diseases market estimates and forecast, 2016 – 2027 (USD Million)
7.3 Diabetes
7.3.1 Diabetes market estimates and forecast, 2016 – 2027 (USD Million)
7.4 Oncology
7.4.1 Oncology market estimates and forecast, 2016 – 2027 (USD Million)
7.5 Cardiology
7.5.1 Cardiology market estimates and forecast, 2016 – 2027 (USD Million)
7.6 Nephrology
7.6.1 Nephrology market estimates and forecast, 2016 – 2027 (USD Million)
7.7 Autoimmune Diseases
7.7.1 Autoimmune diseases market estimates and forecast, 2016 – 2027 (USD Million)
7.8 Drug Testing
7.8.1 Drug testing market estimates and forecast, 2016 – 2027 (USD Million)
7.9 Others
7.9.1 Others market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 8 IVD Market – Segment Analysis, by End Use, 2016 – 2027 (USD Million)
8.1 In Vitro Diagnostic Market: End-use Movement Analysis
8.2 Hospitals
8.2.1 Hospitals market estimates and forecast, 2016 – 2027 (USD Million)
8.3 Laboratory
8.3.1 Laboratory market estimates and forecast, 2016 – 2027 (USD Million)
8.4 Home Care
8.4.1 Home care market estimates and forecast, 2016 – 2027 (USD Million)
8.5 Others
8.5.1 Other market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 9 IVD Market – Segment Analysis, by Region, 2016 – 2027 (USD Million)
9.1 In Vitro Diagnostic Market: Regional Movement Analysis
9.2 North America
9.2.1 North America, SWOT Analysis
9.2.2 North America market estimates and forecast, 2016 – 2027 (USD Million)
9.2.3 U.S.
9.2.3.1 U.S. market estimates and forecast, 2016 – 2027 (USD Million)
9.3 Canada
9.3.1 Canada market estimates and forecast, 2016 – 2027 (USD Million)
9.4 Europe
9.4.1 Europe, SWOT Analysis
9.4.2 Europe market estimates and forecast, 2016 – 2027 (USD Million)
9.4.3 U.K.
9.4.3.1 U.K. market estimates and forecast, 2016 – 2027 (USD Million)
9.4.4 Germany
9.4.4.1 Germany market estimates and forecast, 2016 – 2027 (USD Million)
9.4.5 Spain
9.4.5.1 Spain market estimates and forecast, 2016 – 2027 (USD Million)
9.4.6 France
9.4.6.1 France market estimates and forecast, 2016 – 2027 (USD Million)
9.4.7 Italy
9.4.7.1 Italy market estimates and forecast, 2016 – 2027 (USD Million)
9.4.8 Russia
9.4.8.1 Russia market estimates and forecast, 2016 – 2027 (USD Million)
9.5 Asia Pacific
9.5.1 Asia Pacific, SWOT Analysis
9.5.2 Asia Pacific market estimates and forecast, 2016 – 2027 (USD Million)
9.5.3 Japan
9.5.3.1 Japan market estimates and forecast, 2016 – 2027 (USD Million)
9.5.4 China
9.5.4.1 China market estimates and forecast, 2016 – 2027 (USD Million)
9.5.5 India
9.5.5.1 India market estimates and forecast, 2016 – 2027 (USD Million)
9.5.6 South Korea
9.5.6.1 South Korea market estimates and forecast, 2016 – 2027 (USD Million)
9.5.7 Singapore
9.5.7.1 Singapore market estimates and forecast, 2016 – 2027 (USD Million)
9.5.8 Australia
9.5.8.1 Australia market estimates and forecast, 2016 – 2027 (USD Million)
9.6 Latin America
9.6.1 Latin America, SWOT Analysis
9.6.2 Latin America market estimates and forecast, 2016 – 2027 (USD Million)
9.6.3 Brazil
9.6.3.1 Brazil market estimates and forecast, 2016 – 2027 (USD Million)
9.6.4 Mexico
9.6.4.1 Mexico market estimates and forecast, 2016 – 2027 (USD Million)
9.6.5 Argentina
9.6.5.1 Argentina market estimates and forecast, 2016 – 2027 (USD Million)
9.7 Middle East and Africa
9.7.1 Middle East & Africa, SWOT Analysis
9.7.2 Middle-East and Africa market estimates and forecast, 2016 – 2027 (USD Million)
9.7.3 South Africa
9.7.3.1 South Africa market estimates and forecast, 2016 – 2027 (USD Million)
9.7.4 United Arab Emirates
9.7.4.1 United Arab Emirates market estimates and forecast, 2016 – 2027 (USD Million)
9.7.5 Saudi Arabia
9.7.5.1 Saudi Arabia market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 10 Competitive Analysis
10.1 Recent Developments & Impact Analysis, by Key Market Participants
10.1.1 Ansoff matrix
10.1.2 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
10.1.3 Innovators
10.2 Vendor Landscape
10.2.1 List of key distributors and channel partners
10.2.2 Key company market share analysis, 2020
10.3 Mass Spectrometry
10.3.1 Global mass spectrometry company market share analysis, 2020
10.3.2 North America mass spectrometry company market share analysis, 2020
10.3.3 Europe mass spectrometry company market share analysis, 2020
10.3.4 Asia Pacific mass spectrometry company market share analysis, 2020
10.4 Immunoassay
10.4.1 Global immunoassay company market share analysis, 2020
10.4.2 North America immunoassay company market share analysis, 2020
10.4.3 Europe immunoassay company market share analysis, 2020
10.4.4 Asia Pacific immunoassay company market share analysis, 2020
10.5 PCR
10.5.1 Global PCR company market share analysis, 2020
10.5.2 North America PCR company market share analysis, 2020
10.5.3 Europe PCR company market share analysis, 2020
10.5.4 Asia Pacific PCR company market share analysis, 2020
10.6 Public Companies
10.6.1 Company market position analysis
10.6.2 Competitive Dashboard Analysis
10.6.3 Strategic FramewoRk
10.7 Private Companies
10.7.1 List of key emerging companies /technology disruptors/innovators
10.7.2 Regional network map
10.8 Company Profiles
10.8.1 Abbott
10.8.1.1 Company overview
10.8.1.2 Financial performance
10.8.1.3 Product benchmarking
10.8.1.4 Strategic initiatives
10.8.2 bioMerieux SA
10.8.2.1 Company overview
10.8.2.2 Financial Performance
10.8.2.3 Product benchmarking
10.8.2.4 Strategic initiatives
10.8.3 Bio-Rad Laboratories, Inc.
10.8.3.1 Company overview
10.8.3.2 Financial Performance
10.8.3.3 Product benchmarking
10.8.3.4 Strategic initiatives
10.8.4 Becton, Dickinson and Company
10.8.4.1 Company overview
10.8.4.2 Financial performance
10.8.4.3 Product benchmarking
10.8.4.4 Strategic initiatives
10.8.5 Siemens Healthineers AG
10.8.5.1 Company overview
10.8.5.2 Financial Performance
10.8.5.3 Product benchmarking
10.8.5.4 Strategic initiatives
10.8.6 Qiagen
10.8.6.1 Company overview
10.8.6.2 Financial performance
10.8.6.3 Product benchmarking
10.8.6.4 Strategic initiatives
10.8.7 Quidel Corporation
10.8.7.1 Company overview
10.8.7.2 Financial performance
10.8.7.3 Product benchmarking
10.8.7.4 Strategic initiatives
10.8.8 F. Hoffmann-La Roche AG
10.8.8.1 Company overview
10.8.8.2 Financial performance
10.8.8.3 Product benchmarking
10.8.8.4 Strategic initiatives
10.8.9 Sysmex Corporation
10.8.9.1 Company overview
10.8.9.2 Financial performance
10.8.9.3 Product benchmarking
10.8.9.4 Strategic initiatives
10.8.10 Charles River Laboratories International, Inc
10.8.10.1 Company overview
10.8.10.2 Financial performance
10.8.10.3 Product benchmarking
10.8.10.4 Strategic initiatives
10.8.11 Quest Diagnostics
10.8.11.1 Company overview
10.8.11.2 Financial performance
10.8.11.3 Product benchmarking
10.8.11.4 Strategic initiatives
10.8.12 Agilent Technologies
10.8.12.1 Company overview
10.8.12.2 Financial performance
10.8.12.3 Product benchmarking
10.8.12.4 Strategic initiatives
10.8.13 Danaher Corporation
10.8.13.1 Company overview
10.8.13.2 Financial performance
10.8.13.3 Product benchmarking
10.8.13.4 Strategic initiatives
10.8.13.5 Strategic initiatives- Beckman Coulter, Inc.
10.8.13.6 Strategic initiatives- Leica Biosystems

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global In Vitro Diagnostics Product Market, By Region, 2016 - 2027 (USD Million)
TABLE 5 Global In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 6 Global In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 7 Global In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 8 Global In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 9 North America In Vitro Diagnostics Product Market, By Country, 2016 - 2027 (USD Million)
TABLE 10 North America In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 11 North America In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 12 North America In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 13 North America In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 14 U.S. In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 15 U.S. In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 16 U.S. In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 17 U.S. In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 18 Canada In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 19 Canada In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 20 Canada In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 21 Canada In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 22 Europe In Vitro Diagnostics Product Market, By Country, 2016 - 2027 (USD Million)
TABLE 23 Europe In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 24 Europe In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 25 Europe In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 26 Europe In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 27 U.K. In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 28 U.K. In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 29 U.K. In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 30 U.K. In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 31 Germany In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 32 Germany In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 33 Germany In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 34 Germany America In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 35 France In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 36 France In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 37 France In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 38 France In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 39 Spain In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 40 Spain In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 41 Spain In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 42 Spain In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 43 Italy In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 44 Italy In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 45 Italy In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 46 Italy In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 47 Russia In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 48 Russia In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 49 Russia In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 50 Russia In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 51 Asia Pacific In Vitro Diagnostics Product Market, By Country, 2016 - 2027 (USD Million)
TABLE 52 Asia Pacific In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 53 Asia Pacific In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 54 Asia Pacific In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 55 Asia Pacific In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 56 China In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 57 China In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 58 China In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 59 China In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 60 Japan In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 61 Japan In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 62 Japan In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 63 Japan In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 64 India In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 65 India In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 66 India In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 67 India In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 68 South Korea In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 69 South Korea In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 70 South Korea In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 71 South Korea In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 72 Singapore In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 73 Singapore In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 74 Singapore In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 75 Singapore In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 76 Australia In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 77 Australia In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 78 Australia In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 79 Australia In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 80 Latin America In Vitro Diagnostics Product Market, By Country, 2016 - 2027 (USD Million)
TABLE 81 Latin America In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 82 Latin America In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 83 Latin America In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 84 Latin America In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 85 Brazil In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 86 Brazil In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 87 Brazil In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 88 Brazil In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 89 Mexico In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 90 Mexico In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 91 Mexico In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 92 Mexico In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 93 Argentina In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 94 Argentina In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 95 Argentina In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 96 Argentina In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 97 MEA In Vitro Diagnostics Product Market, By Country, 2016 - 2027 (USD Million)
TABLE 98 MEA In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 99 MEA In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 100 MEA In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 101 MEA In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 102 South Africa In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 103 South Africa In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 104 South Africa In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 105 South Africa In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 106 UAE In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 107 UAE In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 108 UAE In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 109 UAE In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)
TABLE 110 Saudi Arabia In Vitro Diagnostics Product Market, By Product, 2016 - 2027 (USD Million)
TABLE 111 Saudi Arabia In Vitro Diagnostics Product Market, By Technology, 2016 - 2027 (USD Million)
TABLE 112 Saudi Arabia In Vitro Diagnostics Product Market, By Application, 2016 - 2027 (USD Million)
TABLE 113 Saudi Arabia In Vitro Diagnostics Product Market, By End Use, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 In Vitro Diagnostics Market Segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 In vitro diagnostic market snapshot
Fig. 10 Parent market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 In vitro diagnostic market driver impact
Fig. 13 Global population by age group, 2016 & 2027
Fig. 14 In vitro diagnostic market restraint impact
Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 16 Porter’s Five Forces Analysis
Fig. 17 Strategy mapping
Fig. 18 IVD market: Products outlook and key takeaways
Fig. 19 IVD market: Products movement analysis
Fig. 20 Instruments market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 21 Reagents market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 22 Services market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 23 IVD market: Technology outlook and key takeaways
Fig. 24 IVD Market: Technology Movement Analysis
Fig. 25 Immunoassay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 26 Instruments market for immunoassay estimates and forecast, 2016 - 2027 (USD Million)
Fig. 27 Reagents market for immunoassay estimates and forecast, 2016 - 2027 (USD Million)
Fig. 28 Services market for immunoassay estimates and forecast, 2016 - 2027 (USD Million)
Fig. 29 Hematology market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 30 Instruments market for hematology estimates and forecast, 2016 - 2027 (USD Million)
Fig. 31 Reagents market for hematology estimates and forecast, 2016 - 2027 (USD Million)
Fig. 32 Services market for hematology estimates and forecast, 2016 - 2027 (USD Million)
Fig. 33 Clinical chemistry market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 34 Instruments market for clinical chemistry estimates and forecast, 2016 - 2027 (USD Million)
Fig. 35 Reagents market for clinical chemistry estimates and forecast, 2016 - 2027 (USD Million)
Fig. 36 Services market for clinical chemistry estimates and forecast, 2016 - 2027 (USD Million)
Fig. 37 Molecular diagnostics market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 38 Instruments market for molecular diagnostics estimates and forecast, 2016 - 2027 (USD Million)
Fig. 39 Reagents market for molecular diagnostics estimates and forecast, 2016 - 2027 (USD Million)
Fig. 40 Services market for molecular diagnostics estimates and forecast, 2016 - 2027 (USD Million)
Fig. 41 Coagulation market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 42 Instruments market for coagulation estimates and forecast, 2016 - 2027 (USD Million)
Fig. 43 Reagents market for coagulation estimates and forecast, 2016 - 2027 (USD Million)
Fig. 44 Services market for coagulation estimates and forecast, 2016 - 2027 (USD Million)
Fig. 45 Microbiology market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 46 Instruments market for microbiology estimates and forecast, 2016 - 2027 (USD Million)
Fig. 47 Reagents market for microbiology estimates and forecast, 2016 - 2027 (USD Million)
Fig. 48 Services market for microbiology estimates and forecast, 2016 - 2027 (USD Million)
Fig. 49 Others market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 50 Instruments others market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 51 Reagents others market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 52 Services market for other technology estimates and forecast, 2016 - 2027 (USD Million)
Fig. 53 IVD market: Application outlook and key takeaways
Fig. 54 IVD market: Application movement analysis
Fig. 55 Infectious diseases market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 56 Diabetes market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 57 Oncology market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 58 Cardiology market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 59 Nephrology market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 60 Autoimmune diseases market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 61 Drug testing market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 62 Others market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 63 IVD market: End-use outlook and key takeaways
Fig. 64 IVD treatment market: End-use movement analysis
Fig. 65 Hospitals market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 66 Laboratory market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 67 Home care market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 68 Other market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 69 IVD Market: Regional Outlook and Key Takeaways
Fig. 70 IVD market: Regional movement analysis
Fig. 71 North America
Fig. 72 North America, SWOT
Fig. 73 North America market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 74 U.S.
Fig. 75 U.S. market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 76 Canada
Fig. 77 Canada market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 78 Europe
Fig. 79 Europe, SWOT
Fig. 80 Europe market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 81 U.K.
Fig. 82 U.K. market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 83 Germany
Fig. 84 Germany market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 85 Spain
Fig. 86 Spain market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 87 France
Fig. 88 France market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 89 Italy
Fig. 90 Italy market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 91 Russia
Fig. 92 Russia market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 93 Asia Pacific
Fig. 94 Asia Pacific, SWOT
Fig. 95 Asia Pacific market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 96 Japan
Fig. 97 Japan market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 98 China
Fig. 99 China market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 100 India
Fig. 101 India market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 102 South Korea
Fig. 103 South Korea market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 104 Singapore
Fig. 105 Singapore market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 106 Australia
Fig. 107 Australia market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 108 Latin America
Fig. 109 Latin America, SWOT
Fig. 110 Latin America market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 111 Brazil
Fig. 112 Brazil market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 113 Mexico
Fig. 114 Mexico market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 115 Argentina
Fig. 116 Argentina market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 117 Middle East & Africa
Fig. 118 Middle East & Africa, SWOT
Fig. 119 MEA market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 120 South Africa
Fig. 121 South Africa market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 122 United Arab Emirates
Fig. 123 United Arab Emirates market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 124 Saudi Arabia
Fig. 125 Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 126 Ansoff matrix
Fig. 127 Competition categorization
Fig. 128 Company market share analysis
Fig. 129 Global mass spectrometry company market share analysis
Fig. 130 North America mass spectrometry company market share analysis
Fig. 131 Europe mass spectrometry company market share analysis
Fig. 132 Asia Pacific mass spectrometry company market share analysis
Fig. 133 Global immunoassay company market share analysis
Fig. 134 North America immunoassay company market share analysis
Fig. 135 Europe immunoassay company market share analysis
Fig. 136 Asia Pacific immunoassay company market share analysis
Fig. 137 Global PCR company market share analysis
Fig. 138 North America PCR company market share analysis
Fig. 139 Europe PCR company market share analysis
Fig. 140 Asia Pacific PCR company market share analysis
Fig. 141 Company market position analysis
Fig. 142 Company market position analysis
Fig. 143 Company market position analysis
Fig. 144 Company profiles
Fig. 145 Regional Network Map

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の体外診断用医薬品市場2021-2027:製品別、用途別、技術別(免疫化学、分子診断)、最終用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆